COMMUNIQUÉS West-GlobeNewswire

Kane Biotech Secures Largest Single Order of bluestem™ products
24/01/2019
C$440K Order from Major North American Retailer. WINNIPEG, Manitoba, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE, OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”), is pleased to announced that it [...]
Seelos Therapeutics, Inc. Announces Successful Completion of its Merger with Apricus Biosciences, Inc. to Advance Late-Stage Pipeline of Products for Central Nervous System (CNS) Disorders
24/01/2019
NEW YORK, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical [...]
Trident Brands Inc. Subsidiary Brain Armor® Signs NFL Hall of Famer Randy White as National Brand Ambassador
24/01/2019
Brookfield, WI, Jan. 24, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Trident Brands Inc. (OTCQB: TDNT), a biotech and nutraceutical company, today announced it has signed NFL Hall of Famer Randy White as National Brand [...]
Proteon Therapeutics Announces Publication of Results from Phase 3 PATENCY-1 Clinical Trial of Investigational Vonapanitase in Patients with Chronic Kidney Disease
24/01/2019
Results supported the design of ongoing pivotal study and FDA Breakthrough Therapy designation WALTHAM, Mass., Jan. 24, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq: PRTO), a company developing novel, [...]
TESARO, Inc. Provides Notice of Fundamental Change, Conversion Rate Adjustment pursuant to Make-Whole Adjustment Event and Supplemental Indenture
24/01/2019
WALTHAM, Mass., Jan. 24, 2019 (GLOBE NEWSWIRE) -- TESARO, Inc. (the “ Company ” or “ TESARO ”), an oncology-focused biopharmaceutical company, today announced that pursuant to the terms of the Indenture and the First [...]
InspireMD Announces Presentation of Interim Data from Investigator-Initiated Study Comparing CGuard™ EPS with a Conventional Open-Cell Carotid Stent
24/01/2019
CGuard™ EPS shows encouraging interim results verses a conventional carotid stent in absence of any adverse clinical events in the CGuard™ arm Data presented at the LINC 2019 Congress in Leipzig, Germany TEL AVIV, [...]
Pascal Biosciences Commences Cannabinoid Testing of Human Volunteers and Patients
24/01/2019
VANCOUVER, British Columbia, and SEATTLE, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today announced the testing of [...]
Meridian Bioscience Reports First Quarter 2019 Operating Results, Declares Regular First Quarter Cash Dividend, and Provides Updated Fiscal 2019 Guidance
24/01/2019
CINCINNATI, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the first quarter ended December 31, 2018. First Quarter 2019 Highlights: Total revenue [...]
AIT Enters into $32.5 million Commercial Licensing Agreement with Circassia Pharmaceuticals for Its Novel Nitric Oxide Generator and Delivery System for Use in the Hospital Setting in the United States and China
24/01/2019
Additionally, AIT to garner a 15%-20% royalty on gross profit AIT will immediately request to be listed on the NASDAQ stock exchange PMA submission on track for the second quarter of 2019 Company to host a call today, [...]
Neurology Publishes Study Reporting Significant Improvements in Duchenne Muscular Dystrophy Patients Treated with Capricor’s Novel Cell Therapy
24/01/2019
Sustained Cardiac and Skeletal Muscle Function Improvements Shown after a Single Dose of CAP-1002 LOS ANGELES, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Neurology ®, an international peer-reviewed journal, on Wednesday [...]
AxoGen to Participate at AAHS ASPN ASRM 2019 Annual Meetings
24/01/2019
The growing body of clinical evidence supporting the company’s platform for nerve repair will be featured in several presentations during the scientific sessions ALACHUA, Fla., Jan. 24, 2019 (GLOBE NEWSWIRE) -- AxoGen, [...]
NeuroMetrix Reports Q4 and Full Year 2018 Financial Results
24/01/2019
WALTHAM, Mass., Jan. 24, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO), today reported financial and business highlights for the quarter and year ended December 31, 2018. The Company develops and markets [...]
Asterias Provides Top Line 12 Month Data Update for its OPC1 Phase 1/2a Clinical Trial in Severe Spinal Cord Injury
24/01/2019
FREMONT, Calif., Jan. 24, 2019 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE American: AST), a biotechnology company dedicated to developing cell-based therapeutics to treat neurological conditions associated [...]
Auxly Signs Definitive Agreement With Curative Cannabis
24/01/2019
VANCOUVER, British Columbia, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V: XLY) (OTCQX: CBWTF) (the " Company ") is pleased to announce that the Company has signed a definitive agreement (the “ [...]
Emergent BioSolutions Announces Appointment of Robert G. Kramer, Sr. to Its Board of Directors
24/01/2019
GAITHERSBURG, Md., Jan. 24, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced the appointment of Robert G. Kramer, Sr. to the company’s Board of Directors. Mr. Kramer currently serves as [...]
Intellia Therapeutics Names Fred Cohen, M.D., to Board of Directors
24/01/2019
CAMBRIDGE, Mass., Jan. 24, 2019 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both in vivo and [...]
Invitation to C-RAD Web Presentation Year-end Report 2018
24/01/2019
Presentation of the report for the fiscal year 2018: Date: Friday February 8, 2019 / kl. 13:00 CET Venue: Online Presentation Topic: C-RAD Year-end Report 2018 Procedure: Please register online through the website: [...]
FIT Biotech Oy: FIT Biotech plans a reverse share split
24/01/2019
FIT Biotech Oy Company release 24.1.2019 at 09:20 am EET FIT Biotech plans a reverse share split FIT Biotech Oy ("Company", FITBIO: FN Finland) plans to reduce the number of all its shares through a reverse share split [...]
Annual report 2018
24/01/2019
Please see attached file Attachment The_Novozymes_Report_2018

Pages